You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 156 No. 3, 12 FEBRUARY 1996 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (48)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Serologic Response to Treatment of Syphilis in Patients With HIV Infection

Amos M. Yinnon, MD; Patricia Coury-Doniger, RN, FNP; Rita Polito, RN; Richard C. Reichman, MD

Arch Intern Med. 1996;156(3):321-325.


Abstract



Background
Much controversy exists concerning the manifestations, therapy, and response to treatment of syphilis in patients coinfected with the human immunodeficiency virus (HIV).

Objective
To assess the effect of HIV infection on the serologic response to treatment of patients with syphilis.

Methods
Sixty-four HIV-seropositive patients with syphilis were matched with 64 patients with syphilis who were HIV negative. Matching criteria included age (±5 years), sex, race, initial rapid plasma reagin (RPR) titer (±1 dilution), and stage of syphilis at entry. There were 26 matched patients with early syphilis, 26 matched patients with late syphilis, and 12 matched patients with biological false-positive RPR. The HIV-positive patients with early syphilis received three doses of penicillin G benzathine. All other patients received treatment as recommended by the Centers for Disease Control and Prevention, Atlanta, Ga. Our study's major end points were clinical and serologic response to treatment.

Results
All 16 patients with symptomatic syphilis were cured. No patient developed clinical signs of neurosyphilis during the 12-month follow-up period. Twenty-nine (56%) of 52 HIV-positive patients with early or late syphilis did not have a fourfold decrease in RPR titer 6 months after treatment compared with 20 (38%) of 52 matched controls (P=.06). No unique characteristics identifying patients who did not respond serologically could be established. The HIV-positive patients with initial RPR less than 1:32 experienced a significantly slower decrease in RPR at 12 months than did the controls (P<.001).

Conclusions
Patients with syphilis who are HIV positive are less likely to experience serologic improvement after recommended therapy than are patients with syphilis who are HIV negative. Patients with HIV infection who contract syphilis should receive intensive and prolonged follow-up, and consideration should be given to designing alternative regimens.

(Arch Intern Med. 1996;156:321-325)



Author Affiliations



From the Infectious Diseases Unit, University of Rochester Medical Center, Rochester, NY. Dr Yinnon is now with the Shaare Zedek Medical Center, Jerusalem, Israel.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of syphilis in HIV-infected subjects: a systematic review of the literature
Blank et al.
Sex. Transm. Infect. 2011;87:9-16.
ABSTRACT | FULL TEXT  

Preliminary assessment of Treponema pallidum-specific IgM antibody detection and a new rapid point-of-care assay for the diagnosis of syphilis in human immunodeficiency virus-1-infected patients
Rotty et al.
Int J STD AIDS 2010;21:758-764.
ABSTRACT | FULL TEXT  

Factors Determining Serologic Response to Treatment in Patients with Syphilis
Gonzalez-Lopez et al.
Clinical Infectious Diseases 2009;49:1505-1511.
ABSTRACT | FULL TEXT  

Assessment of a real-time PCR test to diagnose syphilis from diverse biological samples
Gayet-Ageron et al.
Sex. Transm. Infect. 2009;85:264-269.
ABSTRACT | FULL TEXT  

Antiretroviral Therapy Is Associated with Reduced Serologic Failure Rates for Syphilis among HIV-Infected Patients
Ghanem et al.
Clinical Infectious Diseases 2008;47:258-265.
ABSTRACT | FULL TEXT  

Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics
Ghanem et al.
Sex. Transm. Infect. 2007;83:97-101.
ABSTRACT | FULL TEXT  

Treating Opportunistic Infections among HIV-Exposed and Infected Children: Recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America
Mofenson et al.
Clinical Infectious Diseases 2005;40:S1-S84.
ABSTRACT | FULL TEXT  

Comparison of the serological response to treatment of early syphilis in HIV positive versus HIV negative individuals
Kingston and Higgins
Sex. Transm. Infect. 2004;80:152-153.
FULL TEXT  

The Clinical Manifestations and Treatment of Sexually Transmitted Diseases in Human Immunodeficiency Virus-Positive Men
Mayer et al.
Clinical Infectious Diseases 2001;32:611-622.
ABSTRACT | FULL TEXT  

Syphilis in pregnancy
Genc and Ledger
Sex. Transm. Infect. 2000;76:73-79.
ABSTRACT | FULL TEXT  

Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features
Singh and Romanowski
Clin. Microbiol. Rev. 1999;12:187-209.
ABSTRACT | FULL TEXT  

How Do HIV+ Patients with Syphilis Respond to Treatment?
Journal Watch Dermatology 1996;1996:17-17.
FULL TEXT  

HOW DO HIV+ PATIENTS WITH SYPHILIS RESPOND TO TREATMENT?
JWatch General 1996;1996:7-7.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.